IP Library Granted Patent US 7,585,075
Granted Patent B2
US 7,585,075 · App. 11/881,727 · Granted Sep 8, 2009

Corneal onlays and wavefront aberration correction to enhance vision

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,585,075
App. No.
11/881,727
Granted
Sep 8, 2009
Kind
B2
Abstract

Devices and methods for improving vision are described. The vision of a person can be corrected using a corneal onlay or a lens positioned between an epithelial cell layer and Bowman's membrane of the person's eye. Wavefront aberrations are measured for the person's eye or eyes, and the aberrations are used to shape the corneal onlay to provide a desired vision correction power, or to shape the person's cornea.

Claims (33)

1. A method for enhancing vision of an individual comprising:

measuring a wavefront aberration of an eye of the individual, the eye comprising an epithelial cell layer and a Bowman's membrane; and

altering an ocular implant element based on the measured wavefront aberration to provide a correction for the wavefront aberration, wherein the altered ocular implant element is placed in the eye between the epithelial cell layer and the Bowman's membrane to correct the wavefront aberration and wherein the posterior surface of the ocular implant is configured to substantially align with the Bowman's membrane.

2. The method of claim 1 , wherein the ocular implant element is a blank without a corrective ocular power or a lens having an optical power.

3. The method of claim 1 , wherein the ocular implant element is a blank without a corrective ocular power or a lens having an optical power, and the step of altering the ocular implant element comprises ablating at least a portion of the blank or lens to provide a correction for the wavefront aberration.

4. The method of claim 3 , wherein the step of altering the ocular implant element comprises ablating at least a portion of the blank to provide a spherical power.

5. The method of claim 1 , further comprising a step of placing the altered ocular implant element in the eye between the epithelial cell layer and the Bowman's membrane.

6. The method of claim 5 , further comprising a step of forming an epithelial flap or epithelial pocket to facilitate placement of the altered ocular implant element in the eye.

7. A method of producing a corneal onlay, comprising:

measuring a wavefront aberration of an eye of an individual, the eye comprising an epithelial cell layer and a Bowman's membrane; and

altering at least a portion of a lens having a fixed optical power to provide a correction for the wavefront aberration of the eye of the individual and wherein the altered lens is placed between the epithelial cell layer and the Bowman's membrane to correct the wavefront aberration and wherein the posterior surface of the ocular implant is configured to substantially align with the Bowman's membrane.

8. The method of claim 7 , further comprising a step of molding the ocular blank or the lens from an ophthalmically acceptable material.

9. The method of claim 7 , wherein altering the ocular blank or the lens comprises ablating at least a portion of the ocular blank or the lens, respectively.

10. The method of claim 7 , wherein altering the ocular blank or the lens comprises ablating at least a portion of the blank or the lens to have a spherical power, respectively.

11. A corneal onlay produced by the method of claim 7 .

12. A method of producing a corneal onlay, comprising:

altering an ocular blank without a corrective ocular power or at least a portion of a lens having a fixed optical power, to provide a correction for a wavefront aberration of an eye of an individual and wherein the altered ocular blank or lens placed between an epithelial cell layer and Bowman's membrane of the individual to correct the wavefront aberration and wherein the posterior surface of the ocular implant is configured to substantially align with the Bowman's membrane.

13. The method of claim 12 , further comprising a step of:

receiving information regarding a wavefront aberration measured for the eye of the individual.

14. The method of claim 12 , further comprising a step of molding the ocular blank or lens from an ophthalmically acceptable material.

15. The method of claim 12 , wherein altering the ocular blank or lens comprises ablating at least a portion of the ocular blank or lens, respectively.

16. The method of claim 12 , wherein altering the ocular blank or lens comprises ablating at least a portion of the blank or lens, respectively, to have a spherical power.

17. A corneal onlay produced by the method of claim 12 .

18. The method of claim 12 , wherein altering the lens comprises using a lathe to alter the lens.

19. The method of claim 18 , wherein the lathe is used directly on the lens, or on an insert for a mold configured to form a corneal onlay.

20. The method of claim 19 , wherein the lathe is used on a metal insert for a thermoplastic mold.

21. A method for enhancing vision of an individual comprising:

measuring a wavefront aberration of an eye of an individual, the eye comprising an epithelial cell layer and a Bowman's membrane;

molding a corneal onlay having an ocular power effective in correcting the vision of an eye of an individual; and

ablating a portion of the eye of the individual to correct the measured wavefront aberration to correct the wavefront aberration and wherein the posterior surface of the ocular implant is configured to substantially align with the Bowman's membrane.

22. The method of claim 21 , further comprising a step of placing the corneal onlay in the eye between the epithelial cell layer and the Bowman's membrane.

23. The method of claim 22 , further comprising a step of forming an epithelial flap or epithelial pocket to facilitate placement of the corneal onlay in the eye.

24. The method of claim 1 , 7 , 12 , or 21 wherein the correction for the wavefront aberration is provided when the altered ocular implant element is located in an eye between the epithelial cell layer and the Bowman's membrane.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 16, 2008
From: COOPERVISION, INC.
To: FORSIGHT LABS, LLC
Reel/Frame 021694/0434 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 10, 2008
From: COOPERVISION INTERNATIONAL HOLDING COMPANY, L.P.
To: FORSIGHT LABS, LLC
Reel/Frame 021670/0605 →